Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: A review of the literature

World Journal of Surgical Oncology

Volumn 3, Issue , 2005, Pages

  Kim, Suk Chul ^a   Kim, Dong Wook ^a   Moadel, Renee M ^b   Kim, Chun K ^a   Chatterjee, Samprit ^a   Shafir, Michail K ^a   Travis, Arlene ^a   Machac, Josef ^a   Krynyckyi, Borys R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; TRACER;

ANALYTIC METHOD; BREAST CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LYMPHOSCINTIGRAPHY; MEDICAL LITERATURE; MEDICAL RESEARCH; MOLECULAR PROBE; MORBIDITY; OUTCOMES RESEARCH; PAIN; PARESTHESIA; QUANTITATIVE ANALYSIS; REVIEW; SENSORY ANALYSIS; SENTINEL LYMPH NODE BIOPSY; SYMPTOMATOLOGY;

EID: 27444433903     PISSN: 14777819     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-3-64     Document Type: Review

References (43)

1. Schrenk P, Rieger R, Shamiyeh A, Wayand W: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000, 88:608-614.
2. Roumen RM, Kuijt GP, Liem IH, van Beek MW: Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 2001, 88:1639-1643.
3. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC: Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002, 183:23-27.
4. Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G: Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 2002, 73:31-36.
5. Temple LK, Baron R, Cody HS, 3rd, Fey JV, Thaler HT, Borgen PI, Heerdt AS, Montgomery LL, Petrek JA, Van Zee KJ: Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 2002, 9:654-662.
6. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM: Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002, 9:745-753.
7. Haid A, Kuehn T, Konstantiniuk P, Koberle-Wuhrer R, Knauer M, Kreienberg R, Zimmermann G: Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 2002, 28:705-710.
8. Leidenius M, Leppanen E, Krogerus L, von Smitten K: Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 2003, 185:127-130.
9. Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME, Voogd AC: Comparison of morbidity between axiliary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003, 29:341-350.
10. Blanchard DK, Donohue JH, Reynolds C, Grant CS: Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003, 138:482-487; discussion 487-488.
11. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003, 349:546-553.
12. Rietman JS, Dijkstra PU, Geertzen JH, Baas P, De Vries J, Dolsma W, Groothoff JW, Eisma WH, Hoekstra HJ: Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma. Cancer 2003, 98:690-696.
13. Peintinger F, Reitsamer R, Stranzl H, Ralph G: Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003, 89:648-652.
14. Baron RH, Fey JV, Borgen PI, Van Zee KJ: Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncol Nurs Forum 2004, 31:691-698.
15. Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK: Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology 2004, 37:73-91.
16. Ronka RH, Pamilo MS, von Smitten KA, Leidenius MH: Breast lymphedema after breast conserving treatment. Acta Oncol 2004, 43:551-557.
17. Rietman JS, Dijkstra PU, Geertzen JH, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma YM, Hoekstra HJ: Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 2004, 11:1018-1024.
18. Langer S, Guenther JM, Haigh PI, Difronzo LA: Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma. Am Surg 2004, 70:881-885.
19. Luini A, Gatti G, Zurrida S, Galimberti V, Paganelli G, Naninato P, Caldarella P, Rotmensz N, Winnikow E, Viale G: The sentinel lymph node biopsy under local anesthesia in breast carcinoma: experience of the European Institute of Oncology and impact on quality of life. Breast Cancer Res Treat 2005, 89:69-74.
20. Ronka R, von Smitten K, Tasmuth T, Leidenius M: One-year morbidity after sentinel node biopsy and breast surgery. Breast 2005, 14:28-36.
21. Hampton T: Surgeons "vote with their feet" for sentinel node biopsy for breast cancer staging. JAMA 2003, 290:3053-3054.
22. Keshtgar MRS, Waddington WA, Lakhani SR, Ell PJ: The Sentinel Node in Surgical Oncology. Edited by Keshtgar MRS et al. Berlin, Heidelberg: Springer-Verlag; 1999.
23. Krynyckyi BR, Kim CK, Shafir MK, Mosci K, Machac J: Breast cancer and its management, the utility and technique of lymphoscintigraphy. In Nuclear Medicine Annual; Philadelphia. Edited by Freeman LM. lipincot William & Wilkins; 2003: 131-169.
24. Mariani G, Erba P, Villa G, Gipponi M, Manca G, Boni G, Buffoni F, Castagnola F, Paganelli G, Strauss HW: Lymphoscintigraphic and intraoperative detection of the sentinel lymph node in breast cancer patients: the nuclear medicine perspective. J Surg Oncol 2004, 85:112-122.
25. Aarsvold JN, Alazraki NP: Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 2005, 35:116-128.
26. Kaleya RN, Heckman JT, Most M, Zager JS: Lymphatic mapping and sentinel node biopsy: a surgical perspective. Semin Nucl Med 2005, 35:129-134.
27. Burak WE, Jr., Walker MJ, Yee LD, Kim JA, Saha S, Hinkle G, Olsen JO, Pozderac R, Farrar WB: Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 1999, 177:445-449.
28. McMasters KM, Wong SL, Tuttle TM, Carlson DJ, Brown CM, Dirk Noyes R, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, Edwards MJ: Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 2000, 231:724-731.
29. Tuttle TM: Technical advances in sentinel lymph node biopsy for breast cancer. Am Surg 2004, 70:407-413.
30. Krynyckyi BR, Shim J, Lim I: Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma. Cancer 2004, 100:654-655; author reply 655-656.
31. Krynyckyi BR, Kim CK: Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma. Cancer 2004, 101:2367-2368; author reply 2368-2369.
32. Rutgers EJ, Jansen L, Nieweg OE, de Vries J, Schraffordt Koops H, Kroon BB: Technique of sentinel node biopsy in breast cancer. Eur J Surg Oncol 1998, 24:316-319.
33. Rietman JS, Dijkstra PU, Geertzen JH, Baas P, De Vries J, Dolsma W, Groothoff JW, Eisma WH, Hoekstra HJ: Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma. Cancer 2003, 100:690-686. Erratum in. Cancer 2004, 100:1991.
34. Krynyckyi BR, Miner M, Ragonese JM, Firestone M, Kim CK, Machac J: Technical aspects of performing lymphoscintigraphy: optimization of methods used to obtain images. Clin Nucl Med 2000, 25:978-985.
35. Krynyckyi BR, Kim CK, Mosci K, Fedorciw BJ, Zhang ZY, Lipszyc H, Machac J: Areolar-cutaneous "junction" injections to augment sentinel node count activity. Clin Nucl Med 2003, 28:97-107.
36. Krynyckyi BR, Kim CK, Goyenechea MR, Chan PT, Zhang ZY, Machac J: Clinical breast lymphoscintigraphy: optimal techniques for performing studies, image atlas, and analysis of images. Radiographics 2004, 24:121-145.
37. Krynyckyi BR, Sata S, Zolty I, Kim CK, Knesaurek K: Reducing exposure from 57Co sources during breast lymphoscintigraphy by optimizing energy windows and other suggested enhancements of acquisition and the display of images. J Nucl Med Technol 2004, 32:198-205.
38. Keshtgar MR, Chicken DW, Waddington WA, Raven W, Ell PJ: A training simulator for sentinel node biopsy in breast cancer: a new standard. Eur J Surg Oncol 2005, 31:134-140.
39. Suga K, Yamamoto S, Tangoku A, Oka M, Kawakami Y, Matsunaga N: Breast sentinel lymph node navigation with three-dimensional interstitial multidetector-row computed tomographic lymphography. Invest Radiol 2005, 40:336-342.
40. Krynyckyi BR, Singh G, Colon D, Kim CK, Travis A, Kim SC, Machac J: Letter to the editor. Eur J Surg Oncol 2005, 31:805-806.
41. Krynyckyi BR, Kim SC, Kim CK: Preoperative lymphoscintigraphy and triangulated patient body marking are important parts of the sentinel node process in breast cancer. World J Surg Oncol 2005, 3:56.
42. 99mTc-labeled sulfur colloid results in consistent sentinel lymph node identification. Ann Surg Oncol 2005, 12:167-172.
43. Lawson LL, Sandler M, Martin W, Beauchamp RD, Kelley MC: Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer. Am Surg 2004, 70:1050-1055; discussion 1055-1056.